NanoMedicine Technology Platform
Genetic Immunity's immune amplification platform technology is used to develop nanomedicines comprised
of two principal components, NanoComp and DermaPrep,
which are designed to work together to treat and/or control chronic diseases. These components in combination
make up the DermaVir Patch which is the Company's lead nanomedicine candidate.
- NanoComp: Antigen composition platform combining a disease specific plasmid DNA
with Genetic Immunity's nanoparticle formulation technology
- DermaPrep: Topical administration device for delivering NanoComp into lymph node dendritic cells
DermaVir Patch: Topical nanomedicine for the treatment of HIV/AIDS containing NanoComp
nanoparticles and delivered via the DermaPrep device
| |
|
